Ovid Therapeutics Inc (NASDAQ:OVID)

1.81
Delayed Data
As of Nov 29
 0.00 / 0.00%
Today’s Change
1.41
Today|||52-Week Range
3.60
-43.77%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Ovid Therapeutics Inc have a median target of 4.50, with a high estimate of 7.00 and a low estimate of 2.00. The median estimate represents a +149.31% increase from the last price of 1.81.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Ovid Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.18
Sales
$0.00
Reporting Date
Mar 14

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -7.22%
 
 
 
 
 
 
Growthannually -144.67%
 
 
 
 
 
 

Sales

Growthquarterly -100.00%
 
 
 
 
 
 
Growthannually -99.30%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.